论文部分内容阅读
肿瘤治疗性疫苗多数临床研究疗效有限.美国FDA批准上市的前列腺癌DC疫苗Provenge,其生存期与对照组相比提高了4.1个月,虽然有效,但距离人们的期望值尚远.人们也期望应用肿瘤干细胞样疫苗获取更好的疗效.
肿瘤慢周期细胞疫苗和临床转化策略
【摘 要】
：
肿瘤治疗性疫苗多数临床研究疗效有限.美国FDA批准上市的前列腺癌DC疫苗Provenge,其生存期与对照组相比提高了4.1个月,虽然有效,但距离人们的期望值尚远.人们也期望应用肿瘤干细胞样疫苗获取更好的疗效.
【机 构】
：
中国医学科学院北京协和医学院,肿瘤医院肿瘤研究所免疫室
【出 处】
：
第十四届全国肿瘤生物治疗大会
【发表日期】
：
2015年9期
其他文献
In the early 1990s, the Philippines embarked on controlling the rage of rabies cases occurring both in animals and humans.A joint working collaboration began between the Department of Agriculture (DA)
会议
Background: Rabies was confirmed in southern Bali in late 2008.Initial dog vaccination and culling of unconfined dogs was not successful to control the disease and by June 2010 rabies has spread to al
会议
Study titled "Human and animal rabies prevention and control cost in Bhutan, 2001-2008: The cost-benefit of dog rabies elimination" was undertaken by Tenzin, et al (2012).The main objective of this st
会议
The World Organisation for Animal Health (OIE) is an inter-governmental standard-setting organisation responsible for improving animal health and welfare and veterinary public health worldwide.Since i
会议
狂犬病作为人畜共患的世界性疾病,也是迄今为止人类唯一病死率高达100％的急性传染病.据卫生部发布的《中国狂犬病防治现状》统计,中国年均因狂犬病导致死亡的人数达2400人以上,居全球第二位.由于人们对狂犬病的恐惧,全球范围内每年约有2000万犬只被无辜扑杀,每一分钟就有38条犬因此丧命.
会议
20世纪90年代初,随着狂犬疫苗的推广,尤其是1993年浓缩狂犬疫苗的应用,江苏省狂犬病疫情逐年下降,1996年仅有病例11例报告,流行趋势与全国基本一致,90年代末,疫情再度回升,至2004年达到高峰.近年来疫情虽保持平稳下降状态,但人狂犬病死亡数在所有法定报告传染病中始终位居前列,2004年至2013年疫情流行造成的PYLL为26100人年,合计PYLLR及SPYLLR总体均呈下降趋势(线性回
会议
Gregorio Torres obtained his veterinary degree in Cordoba University (Spain) and continued his postgraduate education in Glasgow University and London University where he specialised in veterinary epi
会议
Although rabies can be effectively prevented after recognized exposures, there is no established effective therapy for human rabies.The Milwaukee protocol, consisting of therapeutic coma, ketamine, ri
会议
The role of perfusion and the development of surrogate measurements to enable high density T cell cu
Scalable, high quality cell manufacturing is key to providing safe, effective and economically viable cell therapies.In the case of autologous T-cell therapies this entails, high density expansion of
会议
A novel tumor cell-derived microparticle system for highly efficient delivery of oncolytic adenoviru
Oncolytic viruses have been utilized for the treatment of various cancers.However, delivery of the viral particles to tumor cells remains a major challenge.Microparticles (MPs) are vesicle forms of pl
会议